Galmed Pharmaceuticals Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
1.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.15
|
-0.21
|
-0.06
|
-40.00%
|
|
2022-09-30
|
-0.16
|
-0.21
|
-0.05
|
-31.25%
|
|
2022-06-30
|
-0.24
|
-0.15
|
0.09
|
37.50%
|
|
2022-03-31
|
-0.30
|
-0.30
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.30
|
-0.30
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.36
|
-0.31
|
0.05
|
13.89%
|
|
2021-06-30
|
-0.38
|
-0.33
|
0.05
|
13.16%
|
|
2021-03-31
|
-0.38
|
-0.38
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.87
|
|
2021-12-31
|
-1.32
|
|
2020-12-31
|
-1.35
|
|
2019-12-31
|
-0.97
|
|
2018-12-31
|
-0.57
|
|
2017-12-31
|
-0.98
|
|
2016-12-31
|
-1.49
|
|
2015-12-31
|
-0.95
|
|
2014-12-31
|
-0.88
|